tweenvest

IRLAB Therapeutics AB (publ) (OM: IRLAB A)

Health Care · Pharmaceuticals · SE

Skr0.85

+36.77% today · -62.6% 1Y

Public summary
A free snapshot of IRLAB Therapeutics AB (publ), with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

IRLAB Therapeutics AB (publ) (OM: IRLAB A) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $12.52M.

Over the last twelve months the share price has lost 62.6%, trading between 0.62 and 2.44.

Tweenvest scores IRLAB Therapeutics AB (publ) across four factors: quality 35/100, value 79/100. Its strongest factor is value.

IRLAB A price history

Nov 21, 2025 · 1.98Weekly closes 0.85 – 2.32Nov 13, 2026 · 0.85

Key figures

Market cap
$12.52M
Revenue (TTM)
$7.19M
P/E
-2.17
EPS
-0.65
Dividend yield
—
Beta (5Y)
0.59
52-week high
Skr2.44
52-week low
Skr0.62
Avg volume (3M)
—
Shares outstanding
148.71M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Optimi Health Corp.CNSX: OPTI$12.86MCA$3.20+1.91%
Silco Pharmaceuticals LimitedDSE: SILCOPHL$12.77MTk15.400.00%
Peak Processing LimitedASX: PKP$12.71MAU$0.010.00%
PT Phapros TbkIDX: PEHA$12.60MRp268.00-2.19%
Devonian Health Group Inc.TSXV: GSD$12.29MCA$6.30-6.67%
Klaria Pharma Holding AB (publ.)OM: KLAR$12.26MSkr0.50+2.03%
Rize Oncology Inc.OTCPK: RZON.F$12.12M$0.16+39,900.00%
Lobe Sciences Ltd.CNSX: LOBE$11.89MCA$0.050.00%

Browse every Pharmaceuticals company →